Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
121 participants
INTERVENTIONAL
2011-10-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Salivary Proteome and Sensitivity to Bitterness
NCT01079338
Study of Tongue Pressures
NCT00013832
Stimulation of Sensation and Improvement in Swallowing Using Oral Capsaicin
NCT01053286
In-Vivo Assessment of Silver Biomaterial Nano-Toxicity 32 Ppm
NCT01405794
Using Saliva Stimulation to Immediately Improve Heart Failure Inpatient's Thirst Sensation
NCT05325983
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nutritional Beverage #2
Nutritional Beverage with an amino acid Oral 237 ml
Nutritional Beverage
Nutritional Beverage Oral 237 mL
Nutritional Beverage #3
Nutritional Beverage with an amino acid Oral 237 ml
Nutritional Beverage
Nutritional Beverage Oral 237mL
Nutritional Beverage #1
Nutritional Beverage Oral 237 ml
Nutritional Beverage
Nutritional Beverage Oral 237mL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nutritional Beverage
Nutritional Beverage Oral 237mL
Nutritional Beverage
Nutritional Beverage Oral 237 mL
Nutritional Beverage
Nutritional Beverage Oral 237mL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
If female, subject is either postmenopausal for at least 1 year or surgically sterile
Subject reports that he/she has not participated in a research study in the last three months.
Exclusion Criteria
Subject has an autoimmune disorder
Subject has a disorder of gastrointestinal tract or any gastrointestinal surgery in past 12 months.
Subject has food allergy, celiac disease or intolerance to any of the ingredients in the study products
Subject reports history of parasthesia; and/or is currently taking medication/dietary supplements/substances that may cause parasthesia for 4 weeks prior to screening
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vikkie Mustad, PhD
Role: STUDY_CHAIR
Abbott
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The National Food Lab
Livermore, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BK98
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.